{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T02:12:24Z","timestamp":1782526344613,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.eplepsyres.2024.107302","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T09:54:30Z","timestamp":1705485270000},"page":"107302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The impact of antiseizure medication on bone health: A systematic review of animal studies"],"prefix":"10.1016","volume":"200","author":[{"given":"Bushra","family":"Parveen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen Reddy","family":"Penumallu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rahaman","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abida","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabea","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Vohora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"52","key":"10.1016\/j.eplepsyres.2024.107302_bib1","doi-asserted-by":"crossref","first-page":"44326","DOI":"10.1074\/jbc.M111.283481","article-title":"Glucocorticoids and tumor necrosis factor \u03b1 increase oxidative stress and suppress Wnt protein signaling in osteoblasts","volume":"286","author":"Almeida","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejps.2014.05.018","article-title":"Raloxifene preserves phenytoin and sodium valproate induced bone loss by modulating serum estradiol and TGF-\u03b23 content in bone of female mice","volume":"62","author":"Anwar","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.eplepsyres.2024.107302_bib3","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/epi4.12776","article-title":"Fractures in people with epilepsy: a nationwide population-based cohort study","volume":"8","author":"Babunovska","year":"2023","journal-title":"Epilepsia Open"},{"issue":"3","key":"10.1016\/j.eplepsyres.2024.107302_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.eplepsyres.2013.06.020","article-title":"Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study","volume":"106","author":"Bauer","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s001980050161","article-title":"Importance of preclinical studies in the development of drugs for treatment of osteoporosis: a review related to the 1998 WHO guidelines","volume":"9","author":"Bonjour","year":"1999","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106511","article-title":"An explorative literature review of the multifactorial causes of osteoporosis in epilepsy","volume":"100","author":"Diemar","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib7","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s43440-020-00087-1","article-title":"Effects of carbamazepine, eslicarbazepine, valproic acid and levetiracetam on bone microarchitecture in rats","volume":"72","author":"Diemar","year":"2020","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.eplepsyres.2008.03.008","article-title":"Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats","volume":"80","author":"Elwakkad","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.eplepsyres.2024.107302_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.eplepsyres.2013.08.012","article-title":"The effect of levetiracetam on rat bone mass, structure and metabolism","volume":"107","author":"Fekete","year":"2013","journal-title":"Epilepsy Res."},{"issue":"12","key":"10.1016\/j.eplepsyres.2024.107302_bib10","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1007\/s00415-020-10065-5","article-title":"Risk incidence of fractures and injuries: a multicenter video-EEG study of 626 generalized convulsive seizures","volume":"267","author":"Frey","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/a-0963-0054","article-title":"Effects of second-generation antiepileptic drugs compared to first-generation antiepileptic drugs on bone metabolism in patients with epilepsy: a meta-analysis","volume":"51","author":"Fu","year":"2019","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/0003702817734617","article-title":"Side-effects of convulsive seizures and anti-seizure therapy on bone in a rat model of epilepsy","volume":"72","author":"Garip Ustaoglu","year":"2018","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib13","doi-asserted-by":"crossref","unstructured":"GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Apr;18(4):357\u2013375. doi: 10.1016\/S1474\u20134422(18)30454-X. Epub 2019 Feb 14. Erratum in: Lancet Neurol. 2019 May;18(5):e4. PMID: 30773428; PMCID: PMC6416168.","DOI":"10.1016\/S1474-4422(19)30120-6"},{"key":"10.1016\/j.eplepsyres.2024.107302_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1517\/14740338.6.3.267","article-title":"Adverse effects of antiepileptic drugs on bone mineral density in children","volume":"6","author":"Gissel","year":"2007","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106619","article-title":"The effects of antiepileptic drugs on bone health: a systematic review","volume":"173","author":"Griepp","year":"2021","journal-title":"Epilepsy Res."},{"issue":"5","key":"10.1016\/j.eplepsyres.2024.107302_bib16","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/epi.14738","article-title":"Bone fractures from generalized convulsive seizures and status epilepticus-A systematic review","volume":"60","author":"Grzonka","year":"2019","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.eplepsyres.2024.107302_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1535-7511.2008.01288.x","article-title":"Screening Bone Mineral Density in Epilepsy: A Call to Action, but What Action?","volume":"9","author":"Herman","year":"2009","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res. Method."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib19","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1248\/bpb.b17-00482","article-title":"Effects of the antiepileptic drugs phenytoin, gabapentin, and levetiracetam on bone strength, bone mass, and bone turnover in rats","volume":"40","author":"Kanda","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2220\/biomedres.38.297","article-title":"Effects of the antiepileptic drugs topiramate and lamotrigine on bone metabolism in rats","volume":"38","author":"Kanda","year":"2017","journal-title":"Biomed. Res."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2018.02.010","article-title":"The effect of levetiracetam on rat bone mineral density, bone structure and biochemical markers of bone metabolism","volume":"824","author":"Karesova","year":"2018","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib22","article-title":"Effects of carbamazepine on serum parathormone, 25- hydroxyvitamin D, bone specific alkaline phosphatase, C-telopeptide, and osteocalcin levels in healthy rats","volume":"12","author":"Kir","year":"2012","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eplepsyres.2012.09.002","article-title":"Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy","volume":"104","author":"Koo","year":"2013","journal-title":"Epilepsy Res."},{"issue":"5","key":"10.1016\/j.eplepsyres.2024.107302_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900861","article-title":"Tuna bone powder alleviates glucocorticoid-induced osteoporosis via coregulation of the NF-\u03baB and Wnt\/\u03b2-Catenin signaling pathways and modulation of gut microbiota composition and metabolism","volume":"64","author":"Li","year":"2020","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116422","article-title":"How safe is bone health in patients on newer or enzyme inhibitor antiepileptic drugs?","volume":"405","author":"Mitta","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/14740338.2019.1625887","article-title":"An update on the problem of osteoporosis in people with epilepsy taking antiepileptic drugs","volume":"18","author":"Miziak","year":"2019","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000229309","article-title":"Bone disease induced by phenytoin therapy: clinical and experimental study","volume":"62","author":"Moro-Alvarez","year":"2009","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.seizure.2007.11.024","article-title":"How can antiepileptic drugs affect bone mass, structure and metabolism? Lessons from animal studies","volume":"17","author":"Nissen-Meyer","year":"2008","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.eplepsyres.2024.107302_bib29","first-page":"327","article-title":"Effects of vigabatrin on the skeletal system of young rats","volume":"69","author":"Nowi\u0144ska","year":"2012","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib30","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0020-1383(16)47003-8","article-title":"Bone mechanical properties and changes with osteoporosis","volume":"47","author":"Osterhoff","year":"2016","journal-title":"Injury"},{"key":"10.1016\/j.eplepsyres.2024.107302_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2018.05.011","article-title":"The anti-epileptic drugs valproate, carbamazepine and levetiracetam cause bone loss and modulate Wnt inhibitors in normal and ovariectomised rats","volume":"113","author":"Parveen","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.eplepsyres.2024.107302_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/bcpt.12996","article-title":"A cross-sectional study to assess the modulation of wnt inhibitors following anti-epileptic drug therapy and their correlation with vitamin d and receptor activator of nuclear factor \u03ba B ligand in indian women with epilepsy","volume":"123","author":"Parveen","year":"2018","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib33","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2174\/1871530319666190204165207","article-title":"Biomarkers of osteoporosis: an update","volume":"19","author":"Parveen","year":"2019","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.eplepsyres.2024.107302_bib34","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1528-1167.2009.02516.x","article-title":"Adverse effects of valproate on bone: defining a model to investigate the pathophysiology","volume":"51","author":"Senn","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107302_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jns.2014.02.032","article-title":"The effect of topiramate and lamotrigine on rat bone mass, structure and metabolism","volume":"340","author":"Simko","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib36","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5507\/bp.2014.006","article-title":"The effect of lacosamide on bone tissue in orchidectomised male albino Wistar rats","volume":"159","author":"Simko","year":"2015","journal-title":"Biomed. Pap. Med Fac. Univ. Palacky. Olomouc Czech Repub."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eplepsyres.2016.10.005","article-title":"The effect of lamotrigine and phenytoin on bone turnover and bone strength: a prospective study in Wistar rats","volume":"128","author":"Simko","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.eplepsyres.2024.107302_bib38","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.pharep.2019.08.004","article-title":"The effect of gabapentin and pregabalin on bone turnover and bone strength: a prospective study in Wistar rats","volume":"71","author":"Simko","year":"2019","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1254\/jphs.91.313","article-title":"Effects of chronic administration of zonisamide, an antiepileptic drug, on bone mineral density and their prevention with alfacalcidol in growing rats","volume":"91","author":"Takahashi","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174268","article-title":"Intermittent administration sodium valproate has a protective effect on bone health in ovariectomized rats","volume":"906","author":"Tao","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2024.107302_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/ebm2.7","article-title":"A protocol format for the preparation, registration and publication of systematic reviews of animal intervention studies","volume":"2","author":"de Vries","year":"2015","journal-title":"Evid. Based Preclin. Med"},{"key":"10.1016\/j.eplepsyres.2024.107302_bib42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.intimp.2019.01.033","article-title":"Phenobarbital inhibits osteoclast differentiation and function through NF-\u03baB and MAPKs signaling pathway","volume":"69","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121124000172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121124000172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T03:16:46Z","timestamp":1736219806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121124000172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":42,"alternative-id":["S0920121124000172"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107302","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of antiseizure medication on bone health: A systematic review of animal studies","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107302"}}